Therapy of Hepatitis C - Back to the Future

被引:92
|
作者
Liang, T. Jake [1 ]
Ghany, Marc G. [1 ]
机构
[1] NIDDK, NIH, Bethesda, MD 20892 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 370卷 / 21期
关键词
VIRUS-INFECTION; CHRONIC HCV; SOFOSBUVIR; ABT-450/R-OMBITASVIR; DASABUVIR; LEDIPASVIR; RIBAVIRIN;
D O I
10.1056/NEJMe1403619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2043 / 2047
页数:5
相关论文
共 50 条
  • [41] On the Possibility of Eradicating Hepatitis C in Russia
    Kochneva, G., V
    Kartashov, M. Yu
    Krivosheina, E., I
    Kuznetsov, A., I
    Chub, E., V
    Sivolobova, G. F.
    Netesov, S., V
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2021, 36 (01) : 27 - 38
  • [42] Hepatitis C therapy in non-genotype 1 patients: the near future
    Wartelle-Bladou, C.
    Le Folgoc, G.
    Bourliere, M.
    Lecomte, L.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (08) : 525 - 536
  • [43] Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives
    De Re, Valli
    HEPATITIS MONTHLY, 2010, 10 (03) : 231 - 232
  • [44] Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
    Gentile, Ivan
    Buonomo, Antonio Riccardo
    Zappulo, Emanuela
    Borgia, Guglielmo
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (07) : 763 - 773
  • [45] Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients
    Bari, Khurram
    Luckett, Keith
    Kaiser, Tiffany
    Diwan, Tayyab
    Cuffy, Madison
    Schoech, Michael R.
    Safdar, Kamran
    Blackard, Jason T.
    Apewokin, Senu
    Paterno, Flavio
    Sherman, Kenneth E.
    Zucker, Stephen D.
    Anwar, Nadeem
    Shah, Shimul A.
    HEPATOLOGY, 2018, 67 (05) : 1673 - 1682
  • [46] Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register)
    Wiegand, Johannes
    Buggisch, Peter
    Mauss, Stefan
    Boeker, Klaus H. W.
    Klinker, Hartwig
    Mueller, Tobias
    Guenther, Rainer
    Serfert, Yvonne
    Manns, Michael P.
    Zeuzem, Stefan
    Berg, Thomas
    Hinrichsen, Holger
    Pathil, Anita
    Zimmermann, Tim
    Baumgarten, Axel
    Teuber, Gerlinde
    Heyne, Renate
    Lutz, Thomas
    Christensen, Stefan
    Simon, Karl-Georg
    John, Christine
    Huppe, Dietrich
    Schober, Andreas
    Antoni, Christoph
    Weber, Andreas
    Gerken, Guido
    Ullrich, Rainer
    Naumann, Uwe
    Cornberg, Markus
    Goeser, Tobias
    Link, Ralph
    Weigand, Kilian
    Moller, Hjordis
    Jung, Maria-Christina
    Herold, Christoph
    Stoehr, Albrecht
    Geier, Andreas
    von Lucadou, Armand
    Kraus, Michael R.
    Busch, Heiner
    Niederau, Claus
    Protzer, Ulrike
    Sarrazin, Christoph
    Schirmacher, Peter
    Wedemeyer, Heiner
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (11) : 1424 - 1431
  • [47] Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
    Crespo, Javier
    Luis Calleja, Jose
    Fernandez, Inmaculada
    Sacristan, Begona
    Ruiz-Antoran, Belen
    Ampuero, Javier
    Hernandez-Conde, Marta
    Garcia-Samaniego, Javier
    Gea, Francisco
    Buti, Maria
    Cabezas, Joaquin
    Lens, Sabela
    Maria Morillas, Rosa
    Ramon Salcines, Jose
    Manuel Pascasio, Juan
    Turnes, Juan
    Saez-Royuela, Federico
    Arenas, Juan
    Rincon, Diego
    Prieto, Martin
    Jorquera, Francisco
    Sanchez Ruano, Juan Jose
    Navascues, Carmen A.
    Molina, Esther
    Gallego Moya, Adolfo
    Maria Moreno-Planas, Jose
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (06) : 945 - 949
  • [48] Advancements in combination therapy of Hepatitis C virus
    Jahangeer, Muhammad
    Din, Nighat Zia ud
    Karim, Sana
    Hussain, Shoukat
    Ashiq, Mehvish
    Ali, Usman
    ul Haq, Anwar
    Munir, Naveed
    Mahmood, Zahed
    Ghaffar, Abdul
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 33 (05) : 2171 - 2178
  • [49] Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C
    Abdulla, Maheeba
    Al Ghareeb, Aysha Mohamed
    Husain, Hamed Ali Hasan Yusuf
    Mohammed, Nafeesa
    Al Qamish, Jehad
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (34) : 12566 - 12577
  • [50] Individualisation of antiviral therapy for chronic hepatitis C
    Teoh, Narci C.
    Farrell, Geoffrey C.
    Chan, Henry L-Y
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (07) : 1206 - 1216